Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Mead infant formula recall

This article was originally published in The Tan Sheet

Executive Summary

BMS subsidiary initiates voluntary recall of 505 cases of EnfaCare LIPIL 12.9 oz. powdered formula due to contamination with Enterobacter sakazakii bacteria, FDA announces Jan. 9. Cases and cans are coded BME01, with an expiration date of Jan. 1, 2004, and were shipped to hospitals, retail stores and Women, Infant & Children clinics nationwide, firm says. Mead Johnson notes it has not received adverse event reports associated with the batch; E. sakazakii has been linked to rare cases of sepsis, meningitis, necrotizing enterocolitis in newborn infants. Bacteria has posed problems for several powdered infant formula manufacturers in the past; both Mead and Wyeth recalled formula in 2002...

You may also be interested in...

California WIC “Listening Sessions” Will Address Lipid-Enhanced Formulas

The "many changes in the formulation and marketing practices of infant formula in recent years" will be the subject of two upcoming "listening sessions" sponsored by the California Special Supplemental Nutrition Program for Women, Infants & Children

Spin-out A Neat Solution For Sanofi’s Manufacturing Millstone

Stada Grabs GSK Brands In Key EU Markets

Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales in excess of €100m.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts